Page last updated: 2024-08-21

nicotinamide mononucleotide and Cerebral Hemorrhage

nicotinamide mononucleotide has been researched along with Cerebral Hemorrhage in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guan, YF; Kong, YY; Li, GQ; Miao, CY; Wang, P; Wei, CC	1

Other Studies

1 other study(ies) available for nicotinamide mononucleotide and Cerebral Hemorrhage

Article	Year
Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway. Scientific reports, 2017, 04-06, Volume: 7, Issue:1 Topics: Animals; Biomarkers; Brain Injuries; Cell Death; Cerebral Hemorrhage; Disease Models, Animal; Heme Oxygenase-1; Immunohistochemistry; Inflammation Mediators; Mice; Microglia; NAD; Neuroprotection; Neutrophil Infiltration; NF-E2-Related Factor 2; Nicotinamide Mononucleotide; Oxidative Stress; Protective Agents; Signal Transduction; Time Factors	2017

Article

Year

Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway.

Scientific reports, 2017, 04-06, Volume: 7, Issue:1

Topics: Animals; Biomarkers; Brain Injuries; Cell Death; Cerebral Hemorrhage; Disease Models, Animal; Heme Oxygenase-1; Immunohistochemistry; Inflammation Mediators; Mice; Microglia; NAD; Neuroprotection; Neutrophil Infiltration; NF-E2-Related Factor 2; Nicotinamide Mononucleotide; Oxidative Stress; Protective Agents; Signal Transduction; Time Factors

2017